To assess whether generic and specific health-related quality of sures were associated with the survival of patients with COPD life (HRQL) are independently associated with total and specific in two clinical trials (5, 6). These associations were indepenmortality in patients with chronic obstructive pulmonary disease dent of other clinical markers of severity, suggesting that (COPD), we followed until 1999 a cohort of 321 male patients deterioration in HRQL is an independent risk factor leading with COPD, recruited in 1993-1994 at outpatient respiratory clinics.
The use of health-related quality of life (HRQL) measures in and 15% in the bronchodilator test, and clinical stability in the preceding chronic obstructive pulmonary disease (COPD) has currently month. Information was collected by trained nurses on forced spiromeachieved widespread acceptance. Most clinical and therapeutry using standard techniques (9), dyspnea (10-point visual analog scale) tic research on COPD involves the use of different types (10) , presence of any of the 11 comorbid conditions, sociodemographic of HRQL instruments. However, the relationship between variables (age, social class according to occupation, years of formal HRQL and the physiologic components of the disease as education), HRQL (the Spanish versions of St. George's Respiratory well as its role in the natural course of COPD is not wellQuestionnaire [SGRQ] ) (11, 12) , and SF-36 Health Survey (SF-36) (13, understood. 14) . SGRQ contains 50 items that can be divided into three dimensions (symptoms, activity, and impacts), and their scores range from 0 to 100 Generic and respiratory-specific HRQL measures have (worst status) . The SF-36, with eight scales, scoring 0 to 100 (best been associated with disease severity among patients with health), can be summarized into two component summary scores: physi-COPD (1-3) and with their use of resources and rehospitalcal (PCS-36) and mental . Arterial blood gas tensions were ization rate (4). HRQL measures are probably also important collected, if available, during the 6 months before enrollment from the for the survival of these patients. Two generic HRQL meapatients' medical record.
Vital status was assessed through reinterviews, by linkage with the Mortality Register, and by the review of clinical records. The closing date was November 30, 1999. The underlying causes of death were taken from death certificates at the Mortality Register and coded using (Received in original form December 13, 2001; accepted in final form May 22, 2002) the International Classification of Diseases, Ninth Edition (ICD-9). If
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This article has an online data supplement, which is accessible from this issue's Baseline differences of patients according to their vital status at ences between tertiles being statistically significant for SGRQ
(maximum shortness of breath).
total score (log-rank test, p Ͻ 0.001) ( Figure 2 ) and marginally * Mean (SD); median [interquartile range]; number (%).
significant for PCS-36 (p ϭ 0.053) (Figure 3 ). For MCS-36, differences in survival were small and nonsignificant. Both SGRQ total and PCS-36 scores were independently associated with mortality after adjustment for age, FEV 1 , and were different by vital status. When significant differences were ob-BMI (Table 3) . Similar results were obtained using postbronserved, post hoc comparisons were performed to ascertain which dimenchodilator FEV 1 instead of basal FEV 1 . None of the remaining sion or component summary contributed to significance. Kaplan-Meier survival curves and log-rank tests were performed after stratifying by variables, including dyspnea, cough, education, and chronic contertiles of baseline HRQL results and COPD stages according to the ditions were associated with mortality in the multivariate model.
American Thoracic Society (ATS) (15).
In the final adjusted model, a worsening of 1 SD in either the Semiparametric Cox models were used to assess the association SGRQ total or PCS-36 scores was associated with a 30% increase between baseline PCS-36 and MCS-36, and SGRQ total scores and survival time. Different analyses were performed by all-causes and by specific causes for the total follow-up period and for 3-year follow-up. This latest analysis was done to overcome the time dilution effect up (n ϭ 18) were similar to those followed, although none of the former had long-term oxygen therapy (LTOT) (p ϭ 0.08).
* Global T 2 -Hotelling.
Baseline characteristics of patients according to vital status † Post hoc comparisons.
are shown in Table 1 . Subjects who died during follow-up were ‡ Student's t test.
older, had a lower body mass index (BMI), were more impaired § Global T 2 -Hotelling for component summaries. Mann-Whitney U test.
in all clinical characteristics studied, had LTOT more frequently, being independently associated with all-cause mortality in pain total mortality, whereas the corresponding increase for 1 SD tients with COPD (5, 6). In contrast, no relationship between of change in FEV 1 was about 60%. Similar results for both specific HRQL and respiratory mortality was found by Gerardi SGRQ and PCS-36 were obtained when only mortality due to and coworkers (7) in a cohort mainly including patients with respiratory diseases was considered, but the association between COPD. Because this latter study was the only one that included SGRQ total score and mortality was of marginal significance. In specific measures for both HRQL and cause of death, its results contrast, the association between FEV 1 and respiratory mortality could be taken as indicating that the previously reported positive almost doubled. Neither HRQL nor FEV 1 was associated with associations between HRQL and total mortality were not dinonrespiratory mortality (Table 3) . MCS-36 scores did not show rectly relevant to the COPD disease itself. However, the study statistical association with mortality in the multivariate analysis.
included a small number of respiratory deaths (26) , and the An analysis was conducted in a subsample of 213 patients cohort was composed of patients with COPD (87%) and patients with COPD for whom Pa O 2 information was available. Previous without COPD who were followed for a period of up to 5 years models with SGRQ and PCS-36 were expanded with Pa O 2 , and after a rehabilitation program. both total SGRQ and PCS-36 remained significantly associated Our results provide a different picture by showing that HRQL with all-cause and respiratory mortality, whereas Pa O 2 (HR for scores, both generic and respiratory-specific, were consistently all-cause mortality ϭ 0.98 [95%CI: 0.96-0.997] and HR for respiassociated with mortality. This association was stronger with ratory mortality ϭ 0.96 [95%CI: 0.94-0.99]) captured a signifirespiratory than with nonrespiratory mortality, suggesting that cant portion of the FEV 1 -explained variability.
this relationship is specific. According to our results, every four To determine if the association between baseline HRQL and points increase in the SGRQ total score, a figure that has been mortality was stronger at an earlier time point, a subsequent suggested as clinically relevant (11), is associated with an inmodel was restricted to 3-year follow-up data. This period increased risk of global mortality of 5.1% (95% CI: 0.97-9.4%). cluded 61 deaths, of which 31 were due to respiratory diseases. The association between HRQL measures and 3-year all-cause and respiratory mortality increased for both SGRQ total (HR for 1 SD ϭ 1.61 and 1.92, respectively) and PCS-36 (HR for 1 SD ϭ 1.46 and 1.62, respectively) scores, whereas the corresponding associations for FEV 1 remained similar for all-cause mortality (HR for 1 SD ϭ 1.59-1.72) and decreased slightly for respiratory mortality (HR for 1 SD ϭ 1.73-1.90). All HR, except FEV 1 , in the model assessing the association between respiratory mortality and SGRQ were statistically significant (Table 4) . Neither the HRQL scores nor the covariates showed any statistical association with nonrespiratory causes of mortality.
DISCUSSION
To our knowledge this is the first study reporting that both generic and specific baseline HRQL scores are independently associated with both all-cause and respiratory mortality of patients with COPD after adjustment for other relevant clinical and physiopathologic variables. These results provide further support to the notion that health status, as perceived by the patient, is associated with the natural course of COPD, independent of the biologic variables. General HRQL measures have been previously reported as Moreover, at 3-year follow-up the increase in risk for respiratory tained in the final Cox models, but other relevant variables like mortality associated with an addition of four points in the SGRQ dyspnea, cough, and sputum were also tested. Although Pa O 2 was 12.9% (95% CI: 4.5-22%). Thus, our findings substantiate could only be analyzed in a subsample of 213 patients with the claim that a four-point increase should be considered as COPD, for these subjects in the model expanded with Pa O 2 , both clinically relevant. These results suggest that, similar to what is total SGRQ and PCS-36 remained significantly associated with done with FEV 1 (the strongest predictor of mortality in patients all-cause and respiratory mortality. Thus, in no case was the with COPD, also in our study), HRQL scores should be used association between HRQL and mortality accounted for by any for staging and monitoring patients with COPD.
ADJUSTED ASSOCIATION (COX MODELS) BETWEEN BASELINE HEALTH-RELATED QUALITY OF LIFE AND COMPLETE FOLLOW-UP (MEAN: 4.8 YEARS) MORTALITY BY DIFFERENT MORTALITY EVENTS
of these other explored variables. As in a previous study assessing It is important to note that the mental component summary treatment compliance (19), the administration of LTOT in our score of SF-36 (MCS-36) was not associated with mortality, cohort was associated with mortality, but we did not include it whereas some of the scales reflecting mental health (emotional in the multivariate model. Because there is strong evidence, role, social functioning) did show a statistically significant associbased on randomized controlled trials, that LTOT increases suration in the univariate analysis. This observation further contribvival in patients with COPD (20), the most likely explanation utes to the debate about the way in which SF-36 component for its association with mortality is that LTOT behaves as a summary scores were constructed (18) and highlights the need marker of severity, which in our study was already controlled to take both the summary component and the scale scores into for by FEV 1 . account when assessing mental health status.
In accordance with what was expected, HRQL measures, The independence of the HRQL association with mortality both generic and specific, were more strongly associated with allfound in the present study is based on the wide range of variables cause and respiratory mortality with a shorter length of follow-up included in the adjusted model. Only BMI and FEV 1 were re-(3 years). However, no major change was observed in FEV 1 HR, probably supporting the survivor bias effect reported by Anthonisen and coworkers (5). The problem with a shorter follow-up period is the smaller number of events (deaths) observed, which may lead to a decrease in statistical power.
HEALTH-RELATED QUALITY OF LIFE AND 3-YEAR TOTAL AND RESPIRATORY MORTALITY
It may be speculated that some other factors not included in our models could explain the independent effect of HRQL, the
All-Cause Mortality
Respiratory Causes Mortality* response in a timed walking test being one of these variables.
Standard HR † HR (95% CI) Standard HR HR (95% CI)
In fact, the response to the 12-minute walking test after a rehabilitation program was the most powerful predictor of death in the walking test in our model. An alternative reasoning is that both
Model adjusted by age and BMI specific HRQL and walking distance are part of the same construct, as was suggested in a factor analysis of the study of Definition of abbreviations: BMI ϭ body mass index; CI ϭ confidence interval; HR ϭ hazard ratio; PCS-36 ϭ physical component summary of SF-36; SGRQ ϭ Wegner and coworkers (21) in a sample of patients with COPD.
St. George's Respiratory Questionnaire.
Supporting this idea would be the fact that, when SGRQ total * ICD-9 codes: 460-519.
score was substituted by its three dimension scores in the final † Standard HR: standardized hazard ratios are given for a change of 1 SD in the models for all-cause and respiratory mortality, only the HR for corresponding variable.
‡ FEV 1 sign has been changed to facilitate interpretation.
activity showed a CI not including unity, both at complete and between HRQL and mortality could be different for women, 9. Grupo de Trabajo de la SEPAR para la prá ctica de la espirometría en and a replication of the present study in a cohort involving clínica. Normativa para la Espirometría Forzada. Barcelona: Editorial both sexes is needed. Second, in prognostic studies it has been Doyma; 1985. recommended that a representative and a well-defined sample (26) . In our study we achieved a wide spectrum of Questionnaire. Respir Med 1991; 85:25-31. disease severity through a systematic recruitment of patients 
